Sleep and Adolescent Vaccine Immunogenicity Pilot/Observational Study
Eligible age
11–12 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study tests whether the sleep habits of 11-12 years-olds impact their response to a vaccine that protects against meningococcal illness. That vaccine is typically given at that age by primary care doctors, but nobody has studied how sleep affects children's response to it. This could be important because research on adults suggests that sleep affects the immune system. Families will have their child keep their regular sleep schedule during the 5-week study. They will wear a special wristwatch at night to track their sleep. Each day they will fill out a short online form. They and a parent/guardian will come to Cincinnati Children's twice for 1 - 1 ½ hours. During the first visit, the child get the vaccine. During the second, they have a blood test.
Sponsor: Children's Hospital Medical Center, Cincinnati
You may qualify if…
- ✓ Healthy 11-12 years olds who have neither had initial meningococcal vaccination nor known exposure to meningococcal illness.
You may not qualify if…
- ✕ Condition or treatment resulting in immunosuppression
- ✕ Prior severe vaccine reaction
- ✕ Symptoms of clinical insomnia or organic sleep disorder
- ✕ Known neurologic condition or intellectual/developmental disability
- ✕ Use of a medication that impacts sleep
- ✕ Average nightly sleep of 8-8.99 hours (between the two groups)
- ✕ Daily intake of \>1 coffee or "energy drink" or \>2 caffeinated sodas.
Where it's recruiting
Cincinnati
Source: ClinicalTrials.gov · NCT07636525 · last updated 2026-10-19